Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP05010177 Renieroside B2 N-(2R-hydroxy-17Z-hexacosenoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 863.69 C51H93NO9
LMSP05010178 Renieroside B3 N-(2R-hydroxy-20Z-heptacosenoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 877.7 C52H95NO9
LMSP05010154 Stylissoside A N-(2R-hydoxy-heneicosanoyl)-4R-hydroxy-nonadecasphinganine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 817.66 C46H91NO10
LMSP05010130 Temnoside A N-(2R-hydroxy-tricosanoyl)-1-beta-glucosyl-eicosasphinganine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 843.72 C49H97NO9
LMSP05010131 Temnoside B N-(docosanoyl)-1-beta-glucosyl-eicosasphinganine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 813.71 C48H95NO8
LMSP05010118 Termitomycesphin A N-(2R-hydroxy-hexadecanoyl)-1-beta-glucosyl-8-hydroxy,9-methylene-sphing-4E-enine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 743.55 C41H77NO10
LMSP05010097 Termitomycesphin B N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-8-hydroxy,9-methylene-sphing-4E-enine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 771.59 C43H81NO10
LMSP05010099 Termitomycesphin C N-(2R-hydroxy-hexadecanoyl)-1-beta-glucosyl-9-hydroxy,9-methyl-sphing-4E,7E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 743.55 C41H77NO10
LMSP05010098 Termitomycesphin D N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-9-hydroxy-9-methyl-sphing-4E,7E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 771.59 C43H81NO10
LMSP05010100 Termitomycesphin E N-(2R-hydroxy-hexadecanoyl)-1-beta-glucosyl-8-hydroxy,9-methyl-sphing-4E-enine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 745.57 C41H79NO10
LMSP05010101 Termitomycesphin F N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-8-hydroxy,9-methyl-sphing-4E-enine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 773.6 C43H83NO10
LMSP0501AD05 Manbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 973.74 C54H103NO13
LMSP0501AD07 Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 971.73 C54H101NO13
LMSP05010113 N-(2R-hydroxy-hexadecanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 727.56 C41H77NO9
LMSP0501AD08 Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 999.76 C56H105NO13
LMSP05010112 N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 755.59 C43H81NO9
LMSP0501AD06 Manbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 1001.77 C56H107NO13
LMSP05010114 N-(2R-hydroxy-heptadecanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 741.58 C42H79NO9
LMSP0501AD04 Manbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 945.71 C52H99NO13
LMSP0501AD02 Manbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 889.65 C48H91NO13
LMSP0501AD01 Manbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 861.62 C46H87NO13
LMSP0501AD03 Manbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 917.68 C50H95NO13
LMSP05010172 N-(2R-hydroxy-octadecanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 753.58 C43H79NO9
LMSP05010171 N-(2R-hydroxy-heptadecanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 739.56 C42H77NO9
LMSP05010107 N-(2R-hydroxy-3E-heneicosenoyl)-1-beta-glucosyl-9-methyl-heptadecasphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 781.61 C45H83NO9
LMSP05010115 N-(2R-hydroxy-hexdecanoyl)-1-beta-glucosyl-9-methyl-heptadecasphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 713.54 C40H75NO9
LMSP05010108 N-(2R-hydroxy-heneicosanoyl)-1-beta-glucosyl-9-methyl-heptadecasphing-4E,8E-dienine Neutral glycosphingolipids [SP05] Simple Glc series [SP0501] 783.62 C45H85NO9
LMSP0502AT01 Branched Forssman(d18:1/16:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1794.96 C82H146N4O38
LMSP0502AT02 Branched Forssman(d18:1/18:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1822.99 C84H150N4O38
LMSP0502AT03 Branched Forssman(d18:1/20:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1851.02 C86H154N4O38
LMSP0502AT04 Branched Forssman(d18:1/22:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1879.06 C88H158N4O38
LMSP0502AT05 Branched Forssman(d18:1/24:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1907.09 C90H162N4O38
LMSP0502AT07 Branched Forssman(d18:1/24:1(15Z)) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1905.07 C90H160N4O38
LMSP0502AT06 Branched Forssman(d18:1/26:0) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1935.12 C92H166N4O38
LMSP0502AT08 Branched Forssman(d18:1/26:1(17Z)) GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1933.1 C92H164N4O38
LMSP0502AC01 Forssman antigen(d18:1/16:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1429.83 C68H123N3O28
LMSP0502AC02 Forssman antigen(d18:1/18:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1457.86 C70H127N3O28
LMSP0502AC03 Forssman antigen(d18:1/20:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1485.89 C72H131N3O28
LMSP0502AC04 Forssman antigen(d18:1/22:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1513.92 C74H135N3O28
LMSP0502AC05 Forssman antigen(d18:1/24:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1541.95 C76H139N3O28
LMSP0502AC07 Forssman antigen(d18:1/24:1(15Z)) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1539.94 C76H137N3O28
LMSP0502AC06 Forssman antigen(d18:1/26:0) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1569.99 C78H143N3O28
LMSP0502AC08 Forssman antigen(d18:1/26:1(17Z)) GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1567.97 C78H141N3O28
LMSP0502AA01 Gb3(d18:1/16:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1023.67 C52H97NO18
LMSP0502AA02 Gb3(d18:1/18:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1051.7 C54H101NO18
LMSP0502AA03 Gb3(d18:1/20:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1079.73 C56H105NO18
LMSP0502AA04 Gb3(d18:1/22:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1107.76 C58H109NO18
LMSP0502AA05 Gb3(d18:1/24:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1135.8 C60H113NO18
LMSP0502AA07 Gb3(d18:1/24:1(15Z)) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1133.78 C60H111NO18
LMSP0502AA06 Gb3(d18:1/26:0) Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] 1163.83 C62H117NO18